AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,886,898 | -41.7% | 2,019,890 | +1.4% | 0.03% | -46.9% |
Q2 2023 | $22,100,529 | +91.5% | 1,992,834 | +165.0% | 0.05% | +69.0% |
Q1 2023 | $11,541,880 | -19.8% | 751,914 | +15.9% | 0.03% | -25.6% |
Q4 2022 | $14,397,449 | +1441.5% | 648,826 | +1034.2% | 0.04% | +1200.0% |
Q3 2022 | $934,000 | -65.6% | 57,207 | -69.4% | 0.00% | -66.7% |
Q2 2022 | $2,713,000 | -29.6% | 186,702 | +19.6% | 0.01% | -50.0% |
Q2 2021 | $3,856,000 | – | 156,047 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
AtonRa Partners | 18,970 | $121,029 | 0.25% |
Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |